Core Points - The company held its third extraordinary general meeting of shareholders on September 15, 2025, with no resolutions being rejected [1][2] - The meeting was conducted through a combination of on-site and online voting [3] Meeting Details - The meeting took place at 14:30 on September 15, 2025, at the company's lecture hall in Guangzhou [4][5] - A total of 723 shareholders and their authorized representatives attended, representing 461,356,913 shares, which is 32.8732% of the total shares [6][22] - The meeting was legally compliant with relevant laws and regulations [5][20] Voting Results - The following resolutions were passed: 1. Amendment to the Articles of Association: Approved by 450,940,523 shares (97.7422% of votes) [9][26] 2. Revision of Board Meeting Rules: Approved by 451,794,639 shares (97.9274% of votes) [10][27] 3. Revision of Shareholder Meeting Rules: Approved by 451,805,532 shares (97.9297% of votes) [11][28] - The voting results indicate a significant majority in favor of the proposed amendments, with a notable dissent from minority investors on some resolutions [9][10][11] Legal Opinion - The legal opinion provided by the law firm confirmed that the meeting's procedures, participant qualifications, and voting processes were in accordance with the law [13][30]
广州达安基因股份有限公司2025年第三次临时股东会决议公告